Lipitor 20mg
Pro Research Analysisby 
Searched over 200M research papers for "lipitor 20mg"
Consensus Meter
Lipitor 20mg: Efficacy, Safety, and Comparative Studies
Bioequivalence of Atorvastatin Formulations
A study evaluated the bioequivalence of two atorvastatin tablets, Lipitor (Pfizer) and Atorva (Yuhan), in 49 healthy male Korean volunteers. The study followed a crossover design with a two-week washout period. The results showed that Atorva was bioequivalent to Lipitor, as the 90% confidence intervals for the pharmacokinetic parameters were within the acceptable bioequivalence range.
Composition and Dosage
Lipitor tablets are available in various dosages, including 10 mg, 20 mg, 40 mg, and 80 mg. The 20 mg tablets contain atorvastatin calcium along with inactive ingredients such as calcium carbonate, candelilla wax, and lactose monohydrate, among others. The usual starting dose is 10 mg once daily, which can be increased to 20 mg/day if necessary.
Efficacy in Hypercholesterolemia
Lipitor has been shown to be highly effective in treating hypercholesterolemia. In a study involving 76 patients, those treated with Lipitor 10 mg daily experienced a significant reduction in total cholesterol (37.06%) and low-density lipoprotein cholesterol (42.30%) compared to those treated with simvastatin 20 mg daily. Another study confirmed that Lipitor 20 mg daily was effective in reducing LDL cholesterol and total cholesterol levels in hypercholesterolemic patients.
Cardiovascular Benefits Post-PCI
A randomized controlled trial investigated the effects of aggressive lipid-lowering therapy using Lipitor 20 mg daily in Chinese patients after percutaneous coronary intervention (PCI). The study found that patients on the higher dose had significantly better reductions in LDL cholesterol and total cholesterol compared to those on a lower dose (10 mg daily). The higher dose also resulted in fewer cardiovascular events, such as recurring angina and revascularization.
Safety and Tolerability
Lipitor has been found to be safe and well-tolerated in various patient populations. In elderly patients with unstable angina, Lipitor 20 mg daily was effective and did not result in significant adverse effects. Another study comparing the generic formulation of atorvastatin (Atorva) to Lipitor found no significant difference in adverse event rates, confirming the safety of both formulations.
Comparative Efficacy with Other Statins
Lipitor has been compared to other statins like simvastatin, pravastatin, and rosuvastatin. In a study involving patients with hyperlipidemia, Lipitor 20 mg daily was found to be more effective in reducing LDL cholesterol and total cholesterol levels compared to other statins. Additionally, Lipitor showed a significant reduction in inflammatory markers like high-sensitivity C-reactive protein (hs-CRP).
Conclusion
Lipitor 20 mg is a highly effective and safe option for managing hypercholesterolemia and reducing cardiovascular events post-PCI. Its bioequivalence with other formulations like Atorva ensures its reliability, and its comparative efficacy with other statins makes it a preferred choice for lipid-lowering therapy.
Sources and full results
Most relevant research papers on this topic